OncoMed Pharma (OMED) Reports Q2 Loss Per Share of 72c, Maintains FY Guidance

Go back to OncoMed Pharma (OMED) Reports Q2 Loss Per Share of 72c, Maintains FY Guidance
ONCOMED PHARMA (NASDAQ: OMED) Delayed: 0.89 --0 (-0%)
Previous Close $0.89    52 Week High $23.98 
Open $16.48    52 Week Low $8.07 
Day High $0.89    P/E N/A 
Day Low $0.89    EPS $-1.00 
Volume 668